Varied Impact on Global Supply Chains from COVID-19 Pandemic: Report

by Ruth Seeley

Although Chinese manufacturing is resuming, with Foxconn, Apple, Magna, and automotive suppliers announcing they are already up and running again or will be by the end of March, the impact of the COVID-19 outbreak on supply chains has been widespread. Autos, electronics, capital goods, commodities and apparel sectors have experienced slowdowns in sales and availability of parts in their supply chains, according to the latest research by Panjiva, the supply chain intelligence unit of S&P Global Market Intelligence.

The report, which draws on over 50 research articles from Panjiva to analyze the COVID-19 impact on different sectors, highlighted 11 emerging themes on an event-driven basis.

“Many companies are applying lessons learned during the trade war between the U.S. and China,” says Chris Rogers, Supply Chain Research Analyst at S&P Global Market Intelligence. “While many firms are using expedited deliveries to maintain their supply chains, second order effects are also emerging with the apparel industry now seeing a shortage in materials due to an earlier lack of supplies from China. Global supply chains are expected to take an extended period to fully recover.”

Other key findings from the report include:

  • Logistics sector has slowed down rapidly as U.S. seaborne imports from China fell by 21.5% year over year in February
  • The chemicals, autos and technology hardware industries appear to be the most preoccupied with the impact of the virus based on recent company conference calls
  • Tariff lessons come in handy as companies are accelerating their supply chain restructuring efforts
  • Expedited deliveries particularly using airfreight have become more prominent
  • Second order effects are also emerging with the apparel industry now seeing a shortage in materials for manufacturing outside of China
  • Asian revenue exposure seems to matter less than supply chain exposure in the retail sector
  • Healthcare sector should in theory benefit from a global health emergency, but upstream supply shortages can curtail the ability of firms to actually profit from the trend.

Source: S&P Global Market Intelligence

Related Articles

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy